We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+13.55%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$257M
AUM Growth
+$20.3M
Cap. Flow
-$3.38M
Cap. Flow %
-1.32%
Top 10 Hldgs %
33.42%
Holding
167
New
24
Increased
41
Reduced
51
Closed
33

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.37M
2
ULTA icon
Ulta Beauty
ULTA
+$2.18M
3
COP icon
ConocoPhillips
COP
+$2.04M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.97M
5
EMR icon
Emerson Electric
EMR
+$1.81M

Top Sells

Rank Stock Value
1
COF icon
Capital One
COF
+$4.77M
2
UBER icon
Uber
UBER
+$3.19M
3
PANW icon
Palo Alto Networks
PANW
+$2.27M
4
CRWD icon
CrowdStrike
CRWD
+$2.23M
5
DHI icon
D.R. Horton
DHI
+$2.13M

Sector Composition

Rank Sector Weight
1 Industrials 24.01%
2 Healthcare 17.6%
3 Financials 14.71%
4 Technology 12.6%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHW icon
101
Sherwin-Williams
SHW
$82.7B
$484K 0.19%
1,405
-175
-11% -$55.9K
MRNA icon
102
Moderna
MRNA
$21.8B
$480K 0.19%
+6,850
New +$354K
ALL icon
103
Allstate
ALL
$68B
$476K 0.19%
2,000
– –
MMM icon
104
3M
MMM
$90.9B
$455K 0.18%
2,810
– –
CIEN icon
105
Ciena
CIEN
$53.4B
$454K 0.18%
+925
New +$472K
AMAT icon
106
Applied Materials
AMAT
$403B
$452K 0.18%
625
-1,275
-67% -$588K
IBP icon
107
Installed Building Products
IBP
$6.01B
$442K 0.17%
1,925
-400
-17% -$97.2K
MA icon
108
Mastercard
MA
$502B
$432K 0.17%
841
-25
-3% -$12.5K
VEEV icon
109
Veeva Systems
VEEV
$33.1B
$406K 0.16%
2,285
-2,035
-47% -$336K
INCY icon
110
Incyte
INCY
$24.2B
$405K 0.16%
3,575
-12,775
-78% -$1.27M
QSR icon
111
Restaurant Brands International
QSR
$25.7B
$402K 0.16%
5,549
– –
NTRA icon
112
Natera
NTRA
$38.3B
$387K 0.15%
1,425
-3,000
-68% -$640K
HD icon
113
Home Depot
HD
$331B
$378K 0.15%
+1,073
New +$349K
NKE icon
114
Nike
NKE
$61.9B
$377K 0.15%
9,175
-7,724
-46% -$340K
ANET icon
115
Arista Networks
ANET
$227B
$348K 0.14%
+2,050
New +$322K
ADI icon
116
Analog Devices
ADI
$179B
$348K 0.14%
+875
New +$346K
SNPS icon
117
Synopsys
SNPS
$74.4B
$346K 0.13%
+775
New +$364K
DRI icon
118
Darden Restaurants
DRI
$23.3B
$328K 0.13%
1,591
– –
XYL icon
119
Xylem
XYL
$27.3B
$324K 0.13%
2,744
– –
PRU icon
120
Prudential Financial
PRU
$42.4B
$322K 0.13%
2,986
-350
-10% -$35.6K
AXSM icon
121
Axsome Therapeutics
AXSM
$11.2B
$318K 0.12%
+1,300
New +$282K
MDLZ icon
122
Mondelez International
MDLZ
$79.5B
$297K 0.12%
5,141
-1,675
-25% -$101K
IDXX icon
123
Idexx Laboratories
IDXX
$44.1B
$292K 0.11%
555
-3,245
-85% -$1.82M
EVR icon
124
Evercore
EVR
$12.4B
$284K 0.11%
+831
New +$284K
TIGO icon
125
Millicom
TIGO
$16B
$279K 0.11%
3,075
– –
3 4
5
6 7

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return

New England Research & Management's Q2 2026 Portfolio in Review

As of Q2 2026, New England Research & Management held 167 positions worth $257M, up 8.6% from $237M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

New England Research & Management's Q2 2026 filing shows 24 new, 41 increased, 51 reduced and 33 closed positions. Its largest new stake was Ulta Beauty: 4,303 shares worth $1.94M. The largest sale was Capital One, an estimated $4.77M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q2 2026 buy was Ulta Beauty: 4,303 shares worth $1.94M.
  • New England Research & Management added most to AstraZeneca in Q2 2026, an estimated $2.37M increase.
  • New England Research & Management's biggest Q2 2026 reduction was Idexx Laboratories, cutting an estimated $1.82M.
  • New England Research & Management fully exited Capital One in Q2 2026, selling an estimated $4.77M.
  • New England Research & Management's ten largest holdings make up 33% of its $257M portfolio in Q2 2026.
  • New England Research & Management opened 24 new positions and closed 33 in Q2 2026.
  • New England Research & Management's portfolio value rose 8.6% quarter-over-quarter to $257M.

Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.